Heyman Richard A.
SEC Form 4 insider trading activity
Heyman Richard A. has filed 7 SEC Form 4 filings (14 transaction rows) across 2 companies, including ORIC, ELVN, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 28, 2026.
On the most recent filing, Heyman Richard A. is listed as Director at Oric Pharmaceuticals, Inc. Inside the rolling window, Heyman Richard A. reported no open-market purchases and 7 open-market sales totaling $655K in ORIC and ELVN. The largest disclosed transaction in the window is a sale of 9,635 ELVN shares on Jan 8, 2026, worth $241K.
Companies traded
Other insiders at ORIC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$655K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Heyman Richard A. made?
Heyman Richard A. has filed 7 SEC Form 4 filings (14 transaction rows) across 2 companies, including ORIC, ELVN since 2025.
Which companies does Heyman Richard A. trade?
Heyman Richard A. has filed SEC Form 4 disclosures for 2 companies, including ORIC, ELVN.
When was Heyman Richard A.'s most recent SEC Form 4 filing?
Heyman Richard A.'s most recent SEC Form 4 filing on Tracefour is dated Jul 28, 2026.
What is Heyman Richard A.'s total buy and sell value in the current window?
Inside the rolling retention window, Heyman Richard A. bought $0 and sold $655K based on SEC Form 4 filings.
What was Heyman Richard A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,635 ELVN shares on 2026-01-08, worth $241K, per SEC Form 4 filings.